CRWV vs PG: Which Is the Better Buy?
Side-by-side comparison of CoreWeave, Inc. Class A Common Stock and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
CoreWeave, Inc. Class A Common Stock · Technology
$86.76
+45.0% upside to fair value
Med Conviction
Grade B
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
CRWV has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWV |
PG |
| Current Price |
$86.76 |
$147.04 |
| Fair Value Estimate |
$125.80 |
$168.19 |
| Upside to Fair Value |
+45.0%
|
+14.4%
|
| Market Cap |
$47.3B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
36.3x
|
17.6x
|
| Price / Sales |
6.2x
|
4.0x
|
| Price / FCF |
—
|
22.4x
|
| Revenue Growth YoY |
+112.3%
|
+1.5%
|
| Gross Margin |
67.4%
|
50.2%
|
| Operating Margin |
-3.0%
|
22.7%
|
| Return on Equity |
-45.4%
|
29.8%
|
| Dividend Yield |
0% |
2.92% |
| FCF Yield |
—
|
4.47%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
CoreWeave operates a specialized GPU cloud platform purpose-built for generative AI workloads, offering high-performance GPU and CPU compute, storage, networking, and managed services to large enterprises from bare-metal and virtual server options. The business is growing explosively, with revenue up 112.3% year over year in the most recent quarter and a TTM gross margin of 67.4%, but it is doing…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
CRWV |
PG |
| Zone Low |
$94.35 |
$126.14 |
| Zone High |
$106.93 |
$142.96 |
| In Buy Zone? |
Yes
|
No
|